Physician profile
James Uberti
NPI 1083683544
$5,577.33
in general payments reported to CMS, 2019-2025
18 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,203 · 2020: $118 · 2021: $551 · 2022: $562 · 2023: $1,218 · 2024: $1,432 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,143.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,560.42 | 2019-2025 | Jardiance |
| Irhythm Technologies, INC. | $437.64 | 2021-2023 | Zio Xt Patch |
| Abbvie INC. | $397.24 | 2019-2024 | |
| Lilly USA, LLC | $354.50 | 2019-2025 | Jardiance |
| Amgen INC. | $195.51 | 2019 | |
| Novo Nordisk INC | $124.80 | 2024 | |
| Neurocrine Biosciences, INC. | $113.50 | 2024 | Ingrezza |
| Glaxosmithkline, LLC. | $80.22 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $70.10 | 2019-2020 | |
| Amarin Pharma, INC. | $57.17 | 2019 | |
| Cequr Corporation | $49.75 | 2022 | |
| Astellas Pharma US INC | $33.60 | 2019-2020 | |
| Bausch Health US, LLC | $32.98 | 2019 | |
| W. L. Gore & Associates, INC. | $17.80 | 2019 | |
| Merck Sharp & Dohme LLC | $14.49 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $13.38 | 2019 | |
| Amneal Pharmaceuticals LLC | $13.14 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Uberti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.